Shanmugapriya Karuppusamy

Dr. Shanmugapriya Karuppusamy

Biological Sciences, Munster Technological University, Cork, Ireland
+3
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Shanmugapriya KaruppusamyShanmugapriya Karuppusamy
Shanmugapriya Karuppusamy
GRGaurav Rajauria
Gaurav Rajauria
SFStephen Fitzpatrick
Stephen Fitzpatrick
HLHenry Lyons
Henry Lyons
HMHelena Patricia McMahon
Helena Patricia McMahon
COColm O’donnell
Colm O’donnell
Marine algal species comprise of a large portion of polysaccharides which have shown multifunctional properties and health benefits for treating and preventing human diseases. Laminarin, or β-glucan, a storage polysaccharide from brown algae, has been reported to have potential pharmacological properties such as antioxidant, anti-tumor, anti-coagulant, anticancer, immunomodulatory, anti-obesity, anti-diabetic, anti-inflammatory, wound healing, and neuroprotective potential. It has been widely investigated as a functional material in biomedical applications as it is biodegradable, biocompatible, and is low toxic substances. The reported preclinical and clinical studies demonstrate the potential of laminarin as natural alternative agents in biomedical and industrial applications such as nutraceuticals, pharmaceuticals, functional food, drug development/delivery, and cosmeceuticals. This review summarizes the biological activities of laminarin, including mechanisms of action, impacts on human health, and reported health benefits. Additionally, this review also provides an overview of recent advances and identifies gaps and opportunities for further research in this field. It further emphasizes the molecular characteristics and biological activities of laminarin in both preclinical and clinical settings for the prevention of the diseases and as potential therapeutic interventions.

1 December 2018 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
Shanmugapriya KaruppusamyShanmugapriya Karuppusamy
Shanmugapriya Karuppusamy
HKHyejin Kim
Hyejin Kim
Saravana Periaswamy SivagnanamSaravana Periaswamy Sivagnanam
Saravana Periaswamy Sivagnanam
BCByung-Soo Chun
Byung-Soo Chun
HKHyun Wook Kang
Hyun Wook Kang

1 December 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
Shanmugapriya KaruppusamyShanmugapriya Karuppusamy
Shanmugapriya Karuppusamy
HKHyun Wook Kang
Hyun Wook Kang

1 November 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
Shanmugapriya KaruppusamyShanmugapriya Karuppusamy
Shanmugapriya Karuppusamy
HKHyejin Kim
Hyejin Kim
HKHyun Wook Kang
Hyun Wook Kang

1 October 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Shanmugapriya KaruppusamyShanmugapriya Karuppusamy
Shanmugapriya Karuppusamy
HKHyejin Kim
Hyejin Kim
Saravana Periaswamy SivagnanamSaravana Periaswamy Sivagnanam
Saravana Periaswamy Sivagnanam
BCByung-Soo Chun
Byung-Soo Chun
HKHyun Wook Kang
Hyun Wook Kang

1 July 2019 in Ultrasonics Sonochemistry
Verified
Journal Article
Open access
Saravana Periaswamy SivagnanamSaravana Periaswamy Sivagnanam
Saravana Periaswamy Sivagnanam
Shanmugapriya KaruppusamyShanmugapriya Karuppusamy
Shanmugapriya Karuppusamy
CGCollin Rudolf Nobbs Gereniu
Collin Rudolf Nobbs Gereniu
SCSol-Ji Chae
Sol-Ji Chae
HKHyun Wook Kang
Hyun Wook Kang
BCByung-Soo Chun
Byung-Soo Chun
This work aims to produce and optimize a κ-carrageenan-based nanoemulsion (NE) to encapsulate seaweed oil, which is rich in fucoxanthin (FX), using ultrasound-assisted emulsification. κ-Carrageenan was produced using subcritical water, and seaweed oil was extracted using supercritical carbon dioxide with sunflower oil as the co-solvent. Response surface methodology (RSM) was used to understand the influence of several process parameters such as ultrasound amplitude, time, temperature, and duty cycle to produce an NE. The RSM factor was used to focus on droplet size, polydispersity index, zeta potential, viscosity, antioxidant, FX, encapsulation efficiency, and emulsion stability. Our outcomes suggested that the ultrasound process had a noteworthy influence on the NE. The best conditions to obtain an NE were an ultrasound amplitude of 87 µm, a sonication time of 394 s, a temperature of 60 °C, and a duty cycle of 50%. The resulting NE was studied by UV-Vis, Fourier-transform infrared spectroscopy, thermal gravimetric analysis, differential scanning calorimetry, scanning electron microscopy, atomic force microscopy, and X-ray diffraction. Moreover, the NE obtained from optimized conditions was checked for fatty acid content, color, oxidative stability, in vitro digestion, bioaccessibility of FX, and cytotoxicity. The results obtained suggest that lower droplet size of the emulsion can improve oxidative stability, in vitro digestion, bioaccessibility of FX, and good cell inhibition against a few cell lines. Therefore, a κ-carrageenan-stabilized NE can be used as a potential delivery system to endorse applications of seaweed oil, which is rich in FX, in functional foods, beverage systems, and pharmaceuticals.